Table 1. Demographic characteristics of patients with OncoScan analysis results.
Characteristics | Control group (N=485) (No., %) | Chemotherapy group (N=491) (No., %) | Total (N=976) (No., %) |
---|---|---|---|
Trial | |||
CALGB | 66 [14] | 58 [12] | 124 [13] |
IALT | 258 [53] | 266 [54] | 524 [54] |
JBR 10 | 161 [33] | 167 [34] | 328 [34] |
Age | |||
≤55 | 137 [28] | 137 [28] | 274 [28] |
55–64 | 202 [42] | 205 [42] | 407 [42] |
≥65 | 146 [30] | 149 [30] | 295 [30] |
Sex | |||
Female | 139 [29] | 127 [26] | 266 [27] |
Male | 346 [71] | 364 [74] | 710 [73] |
PS | |||
0 | 248 [51] | 252 [51] | 500 [51] |
1–2 | 235 [49] | 238 [49] | 473 [49] |
Histology | |||
Adenocarcinoma | 207 [43] | 207 [42] | 414 [42] |
Squamous cell carcinoma | 218 [45] | 212 [43] | 430 [44] |
Other | 60 [12] | 72 [15] | 132 [14] |
T | |||
T1 | 57 [12] | 64 [13] | 121 [12] |
T2 | 372 [77] | 365 [75] | 737 [76] |
T3/T4 | 54 [11] | 60 [12] | 114 [12] |
N | |||
N0 | 250 [52] | 251 [51] | 501 [52] |
N1 | 167 [35] | 175 [36] | 342 [35] |
N2 | 66 [14] | 63 [13] | 129 [13] |
Surgery | |||
Lobectomy/other | 344 [71] | 333 [68] | 677 [69] |
Pneumonectomy | 141 [29] | 157 [32] | 298 [31] |